Showing results (11-20 of 116) with videos related to
Sort By:
Pageof 12
Clinical Trials (London, England)|January 25, 2014
Considerations in the design of randomized trials to screen for type 2 diabetesJustin B Echouffo-Tcheugui, Philip C ProrokJournal of the National Cancer Institute|October 9, 2024
Design of randomized controlled trials to estimate cancer-mortality reductions from multicancer detection screeningPing Hu, Philip C Prorok, Hormuzd A KatkiBiometrical Journal. Biometrische Zeitschrift|May 19, 2015
Quantification of length-bias in screening trials with covariate-dependent test sensitivitySonya L Heltshe, Karen Kafadar, Philip C ProrokBMC Medical Research Methodology|September 20, 2002
Statistical issues in randomized trials of cancer screeningStuart G Baker, Barnett S Kramer, Philip C ProrokDisease Markers|August 24, 2004
Development tracks for cancer prevention markersStuart G Baker, Barnett S Kramer, Philip C ProrokJournal of Medical Screening|September 24, 2015
Study designs for determining and comparing sensitivities of disease screening testsPhilip C Prorok, Barnett S Kramer, Anthony B MillerBMC Medical Research Methodology|May 20, 2004
Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: extension of the paired availability designStuart G Baker, Barrett S Kramer, Philip C ProrokBMC Cancer|March 19, 2009
Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial CohortJames V Lacey, Aimee R Kreimer, Saundra S Buys, et al.Journal of Medical Screening|October 18, 2008
Early reporting for cancer screening trialsStuart G Baker, Barnett S Kramer, Philip C ProrokCancer Epidemiology|November 25, 2011
Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopyAdeyinka O Laiyemo, Chyke Doubeni, Paul F Pinsky, et al.Pageof 12